Rong ZG - Search Results

1

Bioactivity, pharmacokinetics, and immunogenicity assays in preclinical and clinical trials for recombinant human endostatin.

Hu B, Zhu HW, Zhu LP, Li C, Rong ZG, Xu JM, Wu ZW, Wang JJ, Xu GX. Hu B, et al. Among authors: rong zg. Acta Pharmacol Sin. 2008 Nov;29(11):1357-69. doi: 10.1111/j.1745-7254.2008.00865.x. Acta Pharmacol Sin. 2008. PMID: 18954531

2

A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo.

Xu YF, Zhu LP, Hu B, Rong ZG, Zhu HW, Xu JM, Wu ZW, Wang JJ, Xu GX. Xu YF, et al. Among authors: rong zg. Eur J Pharmacol. 2007 Jun 14;564(1-3):1-6. doi: 10.1016/j.ejphar.2007.01.086. Epub 2007 Feb 15. Eur J Pharmacol. 2007. PMID: 17346697

3

Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities.

Hao Y, Chen J, Wang X, Zhu H, Rong Z. Hao Y, et al. BioDrugs. 2006;20(6):357-62. doi: 10.2165/00063030-200620060-00006. BioDrugs. 2006. PMID: 17176123

4

[On-orbit response variation analysis of FY-3 MERSI reflective solar bands based on Dunhuang site calibration].

Sun L, Guo MH, Xu N, Zhang LJ, Liu JJ, Hu XQ, Li Y, Rong ZG, Zhao ZH. Sun L, et al. Among authors: rong zg. Guang Pu Xue Yu Guang Pu Fen Xi. 2012 Jul;32(7):1869-77. Guang Pu Xue Yu Guang Pu Fen Xi. 2012. PMID: 23016343 Chinese.

5

[Comparisons and analysis of the spectral response functions' difference between FY-2E's and FY2C's split window channels].

Zhang Y, Li Y, Rong ZG. Zhang Y, et al. Among authors: rong zg. Guang Pu Xue Yu Guang Pu Fen Xi. 2010 Jun;30(6):1634-7. Guang Pu Xue Yu Guang Pu Fen Xi. 2010. PMID: 20707165 Chinese.

6

[Field measurement of Gobi surface emissivity spectrum at Dunhuang calibration site of China].

Zhang Y, Li Y, Rong ZG, Hu XQ, Zhang LJ, Liu JJ. Zhang Y, et al. Among authors: rong zg. Guang Pu Xue Yu Guang Pu Fen Xi. 2009 May;29(5):1213-7. Guang Pu Xue Yu Guang Pu Fen Xi. 2009. PMID: 19650456 Chinese.

7

[New method study of sites vicarious calibration for SZ-3/CMODIS].

Hu XQ, Liu JJ, Qiu KM, Fan TX, Zhang YX, Rong ZG, Zhang LJ. Hu XQ, et al. Among authors: rong zg. Guang Pu Xue Yu Guang Pu Fen Xi. 2009 May;29(5):1153-9. Guang Pu Xue Yu Guang Pu Fen Xi. 2009. PMID: 19650442 Chinese.

8

Optimization of flocculation conditions for kaolin suspension using the composite flocculant of MBFGA1 and PAC by response surface methodology.

Yang ZH, Huang J, Zeng GM, Ruan M, Zhou CS, Li L, Rong ZG. Yang ZH, et al. Among authors: rong zg. Bioresour Technol. 2009 Sep;100(18):4233-9. doi: 10.1016/j.biortech.2008.12.033. Epub 2009 May 5. Bioresour Technol. 2009. PMID: 19419858

9

The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin.

Zhang HY, Han QW, Xu YF, Fan YR, Dai QM, Xu JM, Zhu HW, Rong ZG, Wang JJ, Xu GX. Zhang HY, et al. Among authors: rong zg. Cancer Biol Ther. 2005 Feb;4(2):207-12. Epub 2005 Feb 8. Cancer Biol Ther. 2005. PMID: 15753663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters